Marimed (MRMD) Non Operating Income (2016 - 2026)
Marimed (MRMD) posted quarterly Non Operating Income of -$1.2 million for Q1 2026, up 28.6% year-over-year from -$965037.1 in Q1 2025, and up 55.73% quarter-over-quarter from -$2.8 million in Q4 2025.
Marimed (MRMD) Non Operating Income (2016 - 2026) Analysis & Trends
Marimed (MRMD) has reported Non Operating Income for 11 consecutive years, with -$1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income rose 28.6% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at -$7.5 million (down 7.86% YoY), while the FY2025 annual figure was -$8.0 million, down 16.89% from the prior year.
- Non Operating Income climbed to -$1.2 million in Q1 2026 per MRMD's latest filing, from -$2.8 million in the prior quarter.
- Across five years, Non Operating Income topped out at $852000.0 in Q1 2022 and bottomed at -$12.0 million in Q4 2023.
- Historically, Non Operating Income has averaged -$2.2 million across 5 years, with a median of -$1.7 million in 2024.
- Annual changes were most pronounced in 2022 — Non Operating Income surged 155.91% — and 2023, when it tumbled 3505.09%.
- Marimed's Non Operating Income stood at -$334000.0 in 2022, then sank by 3505.09% to -$12.0 million in 2023, then jumped by 84.65% to -$1.8 million in 2024, then plunged by 51.68% to -$2.8 million in 2025, then soared by 55.73% to -$1.2 million in 2026.
- Business Quant data shows MRMD's Non Operating Income at -$1.2 million in Q1 2026, -$2.8 million in Q4 2025, and -$1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Marimed | 28.08 Mn | 17.74 Mn | 16.23 Mn | -1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.97 Mn |
| Mar 31, 2026 | -1.24 Mn |
| Dec 31, 2025 | -2.80 Mn |
| Sep 30, 2025 | -1.78 Mn |
| Jun 30, 2025 | -1.72 Mn |
| Mar 31, 2025 | -1.74 Mn |
| Dec 31, 2024 | -1.85 Mn |
| Sep 30, 2024 | -1.68 Mn |
| Jun 30, 2024 | -1.73 Mn |
| Mar 31, 2024 | -1.62 Mn |
| Dec 31, 2023 | -12.04 Mn |
| Sep 30, 2023 | -3.10 Mn |
| Jun 30, 2023 | -2.54 Mn |
| Mar 31, 2023 | -3.31 Mn |
| Dec 31, 2022 | -334,000.00 |
| Sep 30, 2022 | -530,000.00 |
| Jun 30, 2022 | -849,000.00 |
| Mar 31, 2022 | 852,000.00 |
| Dec 31, 2021 | -435,000.00 |
| Sep 30, 2021 | -488,000.00 |